You are here

Article Text

Article menu
Download PDFPDF
Editorial
Adverse effects and drug interactions
Making medicines safer?
  1. David Phizackerley, DTB Deputy Editor
  1. DTB, BMJ Journals, London, UK
  1. Correspondence to Mr David Phizackerley, DTB, BMJ Journals, London, UK; dphizackerley{at}bmj.com

https://doi.org/10.1136/dtb.2020.000052

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Publication of the First Do No Harm report from the Independent Medicines and Medical Devices Safety Review has highlighted the significant impact that adverse effects of medicines and medical devices has on those who have been harmed.1 The report, commissioned by the Secretary of State for Health and Social Care, focuses on the harms associated with hormone pregnancy tests, sodium valproate and pelvic mesh implants. One of the report’s themes explores the regulation of medicines and devices and the need for reform, recognising that the current regulatory systems for pharmaceutical products and medical devices have gaps and inefficiencies. The report stresses the importance of implementing some high-level changes in the regulation of medicines to strengthen patient safety, and recommends taking patients’ views into account during the decision-making process.1 With the UK’s involvement in the European Medicines Agency due to …

    View Full Text

    Footnotes

    • Competing interests None declared. Refer to the online supplementary files to view the ICMJE form(s).

    • Provenance and peer review Commissioned; externally peer reviewed.